ReviewInternational journal of general medicine2026
Current Understanding on Hypertensive Disorders in Pregnancy.
Review in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertensive disorders of pregnancy (HDP) are a complex spectrum of conditions that develop during gestation, posing significant risk to maternal and fetal health. This disorder encompasses gestational hypertension, preeclampsia, eclampsia, and chronic hypertension during pregnancy, with notably higher prevalence in low- and middle-income countries. By systematically reviewing latest clinical and experimental evidence concerning about HDP, this review aimed to provide a new understanding on risk assessment and clinical prevention strategies for HDP. In addition, there is still controversy over the antihypertensive treatment for pregnant women with mild to moderate hypertension during pregnancy or hypertension without terminal organ damage. It did not still confirm when to start antihypertensive treatment, the better antihypertensive target and recommended drugs. Therefore, this review also elaborated on used antihypertensive drugs and their effects on mother and fetus in recent years. Summarily, our conclusion suggested preventing HDP still requires a multi-faceted approach including diet, exercise and lifestyle habits. More prospective data were necessary to scientifically clarify preventive and therapeutic measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.